top of page

Lipoderma

Pricing: ​

  • Starting at $1,100/Vial 

Lipoderma by Brightcyte represents the next generation of regenerative aesthetics, offering patients a safe, natural, and long-lasting option for soft tissue augmentation and facial rejuvenation. This advanced cryopreserved fat injectable is meticulously processed to preserve the integrity of mature adipocytes and stromal vascular fraction (SVF) components, ensuring optimal cell viability and regenerative potential.

How It Works
Unlike traditional autologous fat grafting, Lipoderma is conveniently cryopreserved, allowing for on-demand treatments without the need for repeat harvesting procedures. Its smooth, uniform consistency ensures ease of injection through fine cannulas, offering precision placement and natural contour restoration.

Benefits

  • Provides immediate volume enhancement along with ongoing skin improvement

  • Enhances skin texture, elasticity, and overall skin quality through regenerative adipose-derived cells

  • Offers advantages compared to hyaluronic acid fillers and collagen-stimulating injectables

  • Uses a biocompatible, living tissue filler that integrates naturally with existing tissues

  • Minimizes the risk of hypersensitivity or allergic reactions

  • Delivers long-lasting, natural-looking results

Recovery and Results
Recovery from Lipoderma treatment is generally well-tolerated, with most patients experiencing mild swelling, bruising, or tenderness in the treated areas. These symptoms typically subside within a few days to a couple of weeks, depending on the treatment method used. Patients are often able to return to light daily activities within a short time, though more intensive exercise should be postponed as advised by your provider. Noticeable improvements in contour and comfort can begin to appear within a few weeks, with optimal results continuing to develop over several months. Consistent follow-up and adherence to aftercare recommendations are key to achieving and maintaining long-term results.

Contact us

bottom of page